Three Things

October 2009
Pharmaceutical Representative;Oct2009, Vol. 39 Issue 10, p9
The article offers developments in the pharmaceutical industry in the U.S. It states that cases of global cancer increased by 30 percent and by 2020, the number will increase by 17 million. Roche AG chief executive officer (CEO) Pascal Soriot will be the head chief operating officer (COO) of the pharmaceutical division of Genentech Inc. Pfizer Inc. agrees to pay about 70 million dollars to settle claims that has illegally tested Trovan on children during a meningitis outbreak.


Related Articles

  • The Top 10: The Year In Review.  // Pharmaceutical Executive;May2010, Vol. 30 Issue 5, p78 

    The article provides updates in the U.S. pharmaceutical industry. Pfizer Inc. has acquired Wyeth for 68 billion dollars deal. Roche Holding AG has completed 47 billion dollars acquisition of Genentech Inc. Johnson & Johnson has acquired Elan's rights and assets in the Alzheimer's Immunotherapy...

  • CORPORATE.  // MondayMorning;4/18/2011, Vol. 18 Issue 15, p2 

    The article offers news briefs related to the U.S. pharmaceutical industry. Roche Holding AG said that its first-quarter 2011 sales fell 9% with the decline in its revenue from the Avastin tumor drug and a stronger Swiss franc. Merck & Co. will resolve an arbitration dispute with Johnson &...

  • SECTION 11: MUSCULOSKELETAL DISORDERS.  // MPR - Pharmacist's Edition;Winter2011/2012, Vol. 5 Issue 4, p198 

    The article offers brief information on several drugs for musculoskeletal disorders such as arthritis or rheumatic disorders along with their indications and adverse effects which include Actemra from Genentech Inc., Ansaid from Pfizer Inc., and Anaprox from F. Hoffmann-La Roche Ltd.

  • Biotech Saved My Life. Baugus, Kimberly // Equities;Nov2007, Vol. 55 Issue 5, p52 

    The article focuses on biotechnology companies Genentech, Roche, and Pfizer, which have had significant impact on cancer treatment through ongoing research and development of new, innovative cancer drugs and therapies. It states that the battle against cancer can be won only with continued...

  • NEWS BRIEFS.  // MondayMorning;4/20/2009, Vol. 17 Issue 15, p5 

    The article offers news briefs related to pharmaceutical industry in the U.S. GlaxoSmithKline PLC and Pfizer Inc. merge into a new company which will develop treatments against HIV virus. Roche Holding AG filed a lawsuit against Mylan Inc. to block the company from acquiring approval from the...

  • Pharmaceutical Company Round-up.  // PharmaWatch: Monthly Review;Jun2009, Vol. 8 Issue 6, p3 

    The article offers updates related to the pharmaceutical industry in the U.S. It notes that the federal government is investing $1 billion for the development of a vaccine. GlaxoSmithKline (GSK) and Pfizer Inc. announce their partnership on HIV businesses. A drug called Avistin from Genentech...

  • Pipeline.  // Pharmaceutical Representative;Jan2010, Vol. 40 Issue 1, p10 

    The article reports developments in the pharmaceutical industry in the U.S. Phase III study that evaluates ocrelizumab in patients with rheumatoid arthritis from Roche Holding AG reveals its primary efficacy endpoints. Findings about Vimbat, an antiepileptic drug from UCB SA, show clinical...

  • The Industry.  // Pharmaceutical Representative;Aug2011, Vol. 41 Issue 8, p7 

    The article offers news briefs related to the pharmaceutical industry in the U.S. Pharmaceutical company Pfizer Inc. plans to sell its animal health and nutrition divisions. F. Hoffmann-La Roche Ltd. has agreed to fully acquire the Heidelberg, Germany-based MTM Laboratories AG. Novartis AG has...

  • A Mega-Merger About-Face as Industry Retools R&D Strategy. Thiel, Karl // BioWorld Insight;4/11/2011, Vol. 19 Issue 15, p1 

    The article reports on the efforts of various pharmaceutical companies in the U.S. to revise their research and development strategy through mergers to address problems related to productivity. Pharmaceutical companies include Eli Lilly & Co., F. Hoffmann-La Roche Ltd., and Novartis AG. Also...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics